Pharmacokinetics Flashcards

1
Q

Define pharmacokinetics

A

The measurement and formal interpretation of changes with time of drug concentrations in one or more different regions of the body in relation to dosing

Pharmacokinetics describes what the body does to the drug. This encompasses its abdorption, distribution, metabolism and elimination

Understanding PK profiles of drugs allows us to:

Develop drugs
Decide on appropriate dosages
Determine dosing regimens
Interpret drug interactions
Adjust doses according to response
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define clearance

A

Clearance is expressed as volume over time, eg mL/min

It is defined as the **volume of blood cleared irreversibly of drug, per unit of time

Pharmacokinetic parameter that describes drug elimination

Important for maintenance dosing

Volume of plasma which contains the total amount of drug removed from the body in unit of time

Drug clearance can be determined in an individual patient by measuring plasma concentration of drug until steady state is achieved

Renal Clearance
Net effect of:

Glomerular filtration
Active secretion and
Passive reabsorption

Only unbound drug is filtered at the glomerulus

Glomerular filtration rate is assumed to be 7.2L/hour for a healthy adult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the volume of distribution

A

Vd is expressed as volume e.g. mL
It represents teh voleume in whcich the amount of drug in the body would need to be uniformly distributed to produce the observed concentrations in the blood.
It is not a real volume

Indicates accumulation of drugs in tissue compartments

  • A drug with a low Vd is mostly water soluble and will stay predominantly in the plasma (ie would not distribute into other sites like adipose tissue)
  • A drug with a large Vd is more likley to move outside of the circulation and bind to other sites (like adipose tissue).

*The larger the Vd the more widespread the drug is within the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define half-life

A

Half-life is expressed as time e.g. hours.
Is calculated as 0.693* Vd / Cl*
It is defined as the time taken for blood/plasma drug conentration to fall by one half

Half life will not change with variations in dose for drugs that follow ‘first-order’ kinetics

Can be used to determine the duration of action of a drug after a single dose

It takes 3-5 half-lives to reach steady state (with constant dosing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the area under the curve

A

It represents the constant plasma conecntration i.e. - when rate of drug administration is equal to rate of drug elimination.
It is expressed as concentration and time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe steady state (Css)

A

Css is expressed as concentration or mg/L.
It describes the concentration of drug in systemic circulation as a function of time post dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe zero-order kinetics

A

Elimination rate does not increase in proportion to dose and concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe first order kinetics

A

Constant proportion of drug is eliminated per unit of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the loading dose

A

It is defined as the inital amount of drug required to reach the target concentration.
It is calculated using Vd.

Loading dose = Vd x target peak concentration or Cp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe maximum concentration or Cmax

A

it is the maximum concentration of the drug, following administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the time to maximum concentration or Tmax

A

The time taken to reach Cmax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe maintenance dose

A

Dose required to maintain target plasma concentration at steady state.

It is calculated by multiplting steady state conecentratuon by clearnace. Expressed as mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List routes of administration

A
  • oral or rectal
  • percutaneous
  • intravemous
  • inhalation
  • intrathecal
  • IV
  • IM

End up in plasma.

If oral –> gut –> plasma but also liver (kidney, urine elimination) - feces direct elimination

IV–> plasma-> breast and seat glands

other routes can end up metabolising drug e.g. IT/CSF end up in plamsa, metabolised by liver etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe absorption, mechanisms of absorption, and variables that affect absorption

A

Before a drug can be distributed to its site of action it must be absorbed

Drugs need to be able to cross biological membrane(s) to reach systemic circulation.

Lipid soluble drugs readily pass through lipid membranes
Ionised drugs have difficulty crossing cell membranes
Aquaporins in cell membranes allow the passage of small uncharged water soluble substances

Passive diffusion and carrier-mediated transport allow movement of drugs through the body

Passive diffusion - molecules travel down concentration gradient. This is the most common form of transport and is influenced by: surface area of membrane exposed to drug, concentration gradient of drug, lipophilicity of drug, ionisation state of drug

Carrier-mediated transport - Requires the involvement of membrane protein for the movement of a drug across a biological membrane. Can be ACTIVE (requires energy) or FACILITATED (not requiring energy)

Active transport: Permits movement of a compound against a concentration gradient or electrochemical gradient.

Variables:
Blood flow
Rich blood supply enhances absorption
Solubility
A drug must be in solution to be absorbed
Ionisation
Many drugs are weak acids or bases
Ionised form does not diffuse readily through cell membranes; unionised form is usually more lipid soluble and more capable of crossing cell membranes (Extent of ionisation is dependent on the pH of the environment)
Formulation
Drug formulations can be manipulated to achieve desirable absorption characteristics (eg slow release or enteric formulations)
Route of administration can affect both onset and magnitude of drug action.
A drug can enter systemic circulation by being injected there (IV) or absorbed from extravascular sites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe oral absorptio

A

Most common route of admin for drugs
Safe, convenient and economical
Can be absorbed from the
Oral cavity (sublingual or buccal administration)
Stomach (noting the high pH in this environment)
Small intestine (major site of absorption of orally administered drugs and pH is close to neutral)
Rectal (can be used for local or systemic effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Parenteral administration

A

Parenteral (drugs administered via injection):

Intravenous (IV)
    Most rapid way of administering a medication (bioavailability is 100% because entire dose enters the systemic circulation directly)
Subcutaneous (Subcut)
    Given beneath the skin into connective tissue or fat immediately underlying the dermis
Intramuscular (IM)
    Injection of drug into the muscle (erratic absorption)
Intrathecal (IT)
    Drugs administered directly into the spinal subarachnoid space (bypasses blood-brain-barrier)
Epidural
    Injection of drug into the spinal canal or outside the dura mater that surrounds the spinal column
17
Q

Describe distribution

A

The process of reversible transfer of a drug between one location and another (one is usually blood) in the body. After a drug enters systemic circulation it can be distributed to various compartments of the body.

Some drugs remain exclusively in the blood

Distribution will depend on

Permeability across tissue barriers
Binding within the compartments
pH partitioning
Fat:water partitioning
18
Q

Describe factors that affect passage across capillaries

A

Depends on molecue

size
lipid solubility
protein binding

Types of capillaries

Continuous
    Only allow diffusion of water and small solutes through intercellular clefts
    e.g. skeletal and smooth muscle, connective tissues, lungs
Fenestrated
    More permeable than continuous capillaries, allowing rapid exchange of fluid and solutes as large as small peptides
    e.g. kidneys, villi of small intestine, choroid plexus
Sinusoids
    Wider and more winding than other capillaries with incomplete basement membrane, large fenestrations, very large clefts.  Allow large proteins to pass through
    e.g. liver, spleen
19
Q

Describe how drugs are distributed in adipose and other fluids/compartments

A

Adipose tissue

Lipid soluble drugs have a high affinity for adipose tissue (and a higher volume of distribution (Vd)

Prone to accumulation –> prolong half life of the drug

Low blood supply to adipose tissue .˙. drugs are delivered there at a slower rate
CNS

Blood brain barrier (BBB) protects the brain from molecules entering (despite high blood-flow)

Allows passage of lipid soluble drugs and small (<400Da) molecules
Becomes more permeable when inflamed (eg meningitis) allowing passage in

Foetus

Placental barrier

Separates blood vessels of mother and fetus to work as a protective barrier
Allows passage of lipid soluble drugs and small (<500Da) molecules

Breast milk

Almost all drugs pass into breast milk
Most drugs pass into breastmilk via passive diffusionhe concentration of drug in the milk is determined by the Milk to Plasma ratio (M/P ratio)
Milk is more lipid, less protein and slightly more acidic than plasma, therefore, drugs which tend to concentrate in milk:

are weak bases
have low plasma protein binding
 are highly lipid soluble
20
Q

Describe metabolism and its key components

A

Metabolism

The process of the chemical modification of a drug

Mainly via enzymes
Liver primary site of metabolism
Other sites include:
    Kidneys
    Lungs
    Intestines

Prodrugs: Drugs that require chemical modification to be activated in order to elicit a therapeutic action (often happens in the liver)

21
Q

Describe the four fates of drugs

A

Most drugs are metabolised into more water soluble compounds that can be excreted.

Drugs can be:

1. Excreted unchanged
2. Undergo functionalisation (phase I reactions- can be oxidation, hydroxylation, demaination, hydrolysis; dominated by CYP450, hepatocytes, manuy drugs, many DDIs) and be directly excreted
3. Undergo conjugation (Phase II reactions) and be directly excreted -- to makes more polar/inserts suitable functional group, increase solubility
4. Undergo functionalisation then conjugation prior to excretion
22
Q

Distinguish between single and multi-compartment models

A

Single compartment model

Simplified model of a human being

The body is a single compartment in which the drug is distributed

Vd : Links the total amount of drug in the body to plasma concentration

Clearance can be described by half-life

After one T1/2 the concentration of drug in plasma will ↓ to half its initial concentration
After two T1/2 the concentration will ↓ to a quarter of initial concentration
After three T1/2 the concentration will ↓ to an eighth of the initial concentration
The longer the T1/2 of a drug the longer the drug will stay in the body after dosing is discontinued
Steady state is achieved after 3-5 x T1/2 of the drug

If the T1/2 means the steady state is not reached soon enough for therapeutic intent then a loading dose may be given to speed up the process.

Size of a loading dose is determined by the Vd
	
	Two compartment:
			Drugs can enter and leave a peripheral compartment only through a central compartment
23
Q

Describe consequences of zero ordr kinetsics

A

Consequences of zero-order (saturation) kinetics:

Duration of action strongly dependent on dose

Relationship between dose and steady state is unpredictable

Variations in metabolism can lead to disproportionate large changes in plasma concentration

cl and half life are no longer constant

24
Q

Define bioavailability

A

The proportion of administered dose that reaches systemic circulation intact (expressed as a fraction of total dose)

Drug crosses membranes of GIT –> portal vein –> liver

May be metabolised
May pass through the liver intact
25
Q

Describe first-pass metabolism

A

Extraction and metabolism of orally ingested drugs (by the liver and sometimes gut wall) before they can reach the systemic circulation.

If a percentage of the drug is metabolised by the liver only the remainder of that drug will be able to enter systemic circulation to exert its effect

Variations between individuals

26
Q

Describe bio-equivalence

A

Refers to two formulations of the same drug containing an identical concentration of the active ingredient in the same form and administered by the same route

Once a patent expires on a drug other companies can produce generic equivalents of the original drug

Generics must be tested against the original project to determine its relative exposure

To be considered bioequivalent the new (generic) drug must respond within a 20% variance of the original formulation AND have no clinically important differences between their therapeutic or adverse effects

27
Q

List some special populations where pharmacokinetics of drugs are altered

A
  • pregnancy
  • breastfeeding
  • children